MODELING OF ACUTE ASPIRATION BRONCHOPNEUMONIA
Abstract
There is currently an urgent need to create an available experimental model to reproduce the main pathogenetic mechanisms of COVID-associated lung injury. The first stage of such a model may be the reproduction of acute aspiration bronchopneumonia in rats. Aim – to establish an effective and biologically safe model of acute aspiration bronchopneumonia. Methods. A group of laboratory Wistar rats (n=20) with full observance of bioethical norms under thiopental anesthesia underwent surgery with the introduction into the trachea of sterile nylon thread 2.5 cm long and 0.2 mm thick to a depth of 2.5 cm; in the control group included 5 animals. On days 7 and 21, the animals were removed from the experiment, made pathomorphological, cytological and hematological studies. The MedStat program (USA) was used for statistical surveys. Results. During the observation, the animals developed cyanosis of the skin and mucous surfaces, breathing became difficult with the active involvement of the respiratory muscles, severe rales and crepitation were heard. Rectal temperature increased by 1-1.5oC. On the 21st day, the granulocyte-lymphocyte index increased (1.5 times; p=0.003). On sectional examination after 7 days, the lungs were swollen, pale pink in color, had layers of fibrin, severe cyanosis, intra-tissue hemorrhage. After 21 days, these changes were supplemented by the development of atelectasis and fibrosis. Cytological examination showed proliferation of fibrous tissue with activation of biosynthetic processes, severe dystrophy of the bronchial epithelium, lymphoid infiltration. Conclusion. The model of acute aspiration bronchopneumonia in rats allows to obtain the main clinical and morphological manifestations of acute lung damage with cyanosis, shortness of breath, wet wheezing and crepitation, and in the lungs – edema, hemorrhage, active fibrosis.
References
Ackermann, M., Verleden, S. E., Kuehnel, M., Haverich, A., Welte, T., Laenger, F., Vanstapel, A., Werlein, C., Stark, H., Tzankov, A., Li, W. W., Li, V. W., Mentzer, S. J., & Jonigk, D. (2020). Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. The New England journal of medicine, 383(2), 120–128. https://doi.org/10.1056/NEJMoa2015432
Alharthy, A., Faqihi, F., Memish, Z. A., & Karakitsos, D. (2020). Lung Injury in COVID-19-An Emerging Hypothesis. ACS chemical neuroscience, 11(15), 2156–2158. https://doi.org/10.1021/acschemneuro.0c00422.
Boudewijns, R., Thibaut, H.J., Kaptein, S.J.F. et al. STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters. Nat Commun 11, 5838 (2020). https://doi.org/10.1038/s41467-020-19684-y
Cai, A., McClafferty, B., Benson, J., Ramgobin, D., Kalayanamitra, R., Shahid, Z., Groff, A., Aggarwal, C. S., Patel, R., Polimera, H., Vunnam, R., Golamari, R., Sahu, N., Bhatt, D., & Jain, R. (2020). COVID-19: Catastrophic Cause of Acute Lung Injury. South Dakota medicine : the journal of the South Dakota State Medical Association, 73(6), 252–260.
Chung, M., Bernheim, A., Mei, X., Zhang, N., Huang, M., Zeng, X., Cui, J., Xu, W., Yang, Y., Fayad, Z. A., Jacobi, A., Li, K., Li, S., & Shan, H. (2020). CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV). Radiology, 295(1), 202–207. https://doi.org/10.1148/radiol.2020200230
COVID-19. (2021). Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University.
Franks, T. J., Chong, P. Y., Chui, P., Galvin, J. R., Lourens, R. M., Reid, A. H., Selbs, E., McEvoy, C. P., Hayden, C. D., Fukuoka, J., Taubenberger, J. K., & Travis, W. D. (2003). Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Human pathology, 34(8), 743–748. https://doi.org/10.1016/s0046-8177(03)00367-8
Gallelli, L., Zhang, L., Wang, T., & Fu, F. (2020). Severe Acute Lung Injury Related to COVID-19 Infection: A Review and the Possible Role for Escin. Journal of clinical pharmacology, 60(7), 815–825. https://doi.org/10.1002/jcph.1644
George, P. M., Wells, A. U., & Jenkins, R. G. (2020). Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. The Lancet. Respiratory medicine, 8(8), 807–815. https://doi.org/10.1016/S2213-2600(20)30225-3
Golden, J. W., Cline, C. R., Zeng, X., Garrison, A. R., Carey, B. D., Mucker, E. M., White, L. E., Shamblin, J. D., Brocato, R. L., Liu, J., Babka, A. M., Rauch, H. B., Smith, J. M., Hollidge, B. S., Fitzpatrick, C., Badger, C. V., & Hooper, J. W. (2020). Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease. JCI insight, 5(19), e142032. https://doi.org/10.1172/jci.insight.142032
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., Xiao, Y., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England), 395(10223), 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
Kempuraj, D., Selvakumar, G. P., Ahmed, M. E., Raikwar, S. P., Thangavel, R., Khan, A., Zaheer, S. A., Iyer, S. S., Burton, C., James, D., & Zaheer, A. (2020). COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry, 26(5-6), 402-414. https://doi.org/10.1177/1073858420941476
Kubyshkin, A. V., & Fomochkina, I. I. (2008). Ukrains'kyi biokhimichnyi zhurnal (1999), 80(1), 89–95.
Leist, S. R., Dinnon, K. H., 3rd, Schäfer, A., Tse, L. V., Okuda, K., Hou, Y. J., West, A., Edwards, C. E., Sanders, W., Fritch, E. J., Gully, K. L., Scobey, T., Brown, A. J., Sheahan, T. P., Moorman, N. J., Boucher, R. C., Gralinski, L. E., Montgomery, S. A., & Baric, R. S. (2020). A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice. Cell, 183(4), 1070–1085.e12. https://doi.org/10.1016/j.cell.2020.09.050
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., Bi, Y., Ma, X., Zhan, F., Wang, L., Hu, T., Zhou, H., Hu, Z., Zhou, W., Zhao, L., Chen, J., … Tan, W. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet (London, England), 395(10224), 565–574. https://doi.org/10.1016/S0140-6736(20)30251-8.
Ojo, A. S., Balogun, S. A., Williams, O. T., & Ojo, O. S. (2020). Pulmonary Fibrosis in COVID-19 Survivors: Predictive Factors and Risk Reduction Strategies. Pulmonary medicine, 2020, 6175964. https://doi.org/10.1155/2020/6175964
Polidoro, R. B., Hagan, R. S., de Santis Santiago, R., & Schmidt, N. W. (2020). Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19. Frontiers in immunology, 11, 1626. https://doi.org/10.3389/fimmu.2020.01626
Qu, L., Li, J., & Ren, H. (2020). COVID-19: the epidemiology and treatment. British journal of hospital medicine (London, England : 2005), 81(10), 1–9. https://doi.org/10.12968/hmed.2020.0580
Rogovyy, Yu. E., Kopchuk, T. G., Filipova, L. O., & Dical, M. V. (2014). [The pathogenesis of disorders of the functional-biochemical state of the kidneys in the development of aseptic fever]. Modern problems of science and education, (2), 380-380.
Suster, S., Moran, A.C. (2013) Biopsy interpretation of the lung. 1st ed. Lippincott Williams & Wilkins, Wolters Kluwer.
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., Zhao, Y., Li, Y., Wang, X., & Peng, Z. (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 323(11), 1061–1069. https://doi.org/10.1001/jama.2020.1585
World Health Organization. (2020). World Health Organization coronavirus disease (COVID-19) dashboard.

This work is licensed under a Creative Commons Attribution 4.0 International License.
ISSN
ISSN 














